Listed

TherapeuticsMD, Inc.

TXMDNasdaqCIK 25743HealthcareFiscal year ends Dec 31

Reports and events: 392 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

TherapeuticsMD, Inc., Reports and events
FiledFormWhat it isAccession number
2017-11-1316:32 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-17-005435
2017-11-0717:53 ET10-QQuarterly reportPeriod 2017-09-300001387131-17-005313
2017-11-0606:05 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-17-005292
2017-10-0406:45 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-17-004944
2017-09-2807:37 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193125-17-296671
2017-09-2506:56 ET8-K3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-17-004745
2017-09-1206:55 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-17-004625
2017-08-1016:05 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-17-004045
2017-08-0317:28 ET10-QQuarterly reportPeriod 2017-06-300001387131-17-003894
2017-08-0316:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001387131-17-003882
2017-07-1707:32 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-17-003644
2017-06-1916:30 ET8-K5.07 Shareholder vote results0001387131-17-003317
2017-05-3117:10 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-17-003091
2017-05-0807:58 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001387131-17-002494
2017-05-0318:01 ET10-QQuarterly reportPeriod 2017-03-310001387131-17-002419
2017-05-0216:30 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001387131-17-002408
2017-04-2517:01 ETDEF 14AProxy statementPeriod 2017-06-160001387131-17-002244
2017-04-1008:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001387131-17-001997
2017-03-2217:03 ETSC 13D/AOwnership report, active investor, amended0001387131-17-001567
2017-03-0108:17 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-17-001117
2017-02-2816:35 ET10-KAnnual reportPeriod 2016-12-310001387131-17-001111
2017-02-2306:45 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001387131-17-001038
2017-01-0916:41 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-17-000136
2016-12-0816:31 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-16-008405
2016-12-0516:11 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-16-008355
2016-11-0416:37 ET10-QQuarterly reportPeriod 2016-09-300001387131-16-007716
2016-11-0316:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001387131-16-007692
2016-09-2606:46 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-16-007059
2016-09-1917:22 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001387131-16-007014
2016-08-2206:48 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-16-006711
2016-08-0521:11 ET10-QQuarterly reportPeriod 2016-06-300001387131-16-006337
2016-08-0416:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001387131-16-006326
2016-07-0717:02 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-16-005974
2016-06-2917:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-16-005927
2016-06-2016:32 ET8-K5.07 Shareholder vote results0001387131-16-005868
2016-05-0516:31 ET10-QQuarterly reportPeriod 2016-03-310001387131-16-005278
2016-05-0406:03 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-16-005241
2016-05-0316:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001387131-16-005235
2016-04-2806:06 ETDEF 14AProxy statementPeriod 2016-06-160001193125-16-560833
2016-03-0716:36 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-16-004494
2016-02-2616:33 ET10-KAnnual reportPeriod 2015-12-310001387131-16-004361
2016-02-2516:04 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001387131-16-004340
2016-01-1208:01 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193125-16-427327
2015-12-2216:48 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001387131-15-003704
2015-12-0716:26 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-15-003552
2015-11-1708:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-15-003452
2015-11-0516:15 ET10-QQuarterly reportPeriod 2015-09-300001387131-15-003188
2015-11-0416:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001387131-15-003174
2015-10-1307:05 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-15-002981
2015-08-1708:31 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-15-002556

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 19:24 ET. Listed shows no prices and gives no investment advice.